AI driven biology Biohub emphasizes AI-powered biology and large-scale compute for disease research, presenting a sales opportunity for AI platforms, cloud compute credit programs, and data analytics tooling that accelerates drug discovery and functional genomics projects.

CRISPR & delivery Recent method developments use centrifuge-generated forces for CRISPR delivery, signaling openness to partnerships around gene editing delivery technologies, high-throughput screening, and associated bioprocess equipment vendors.

Protein modeling Active updates to ESM protein language models and protein biology world models indicate a need for computational biology software, protein design platforms, and data resources that integrate with their modeling workflows.

Partnership expansion Biohub has ongoing collaborations, including with Every Cure, suggesting opportunities for co-development, AI-driven repurposing initiatives, and grant-aligned programs with philanthropic or nonprofit funding networks.

Funding and scale With substantial revenue and a mid-size to larger employee base, Biohub is positioned to invest in enterprise software, data infrastructure, security, and healthcare-focused AI solutions that scale across research operations and imaging/measurement platforms.